Chennai, Sept. 22 -- Amid wide criticisms from the Opposition and from Left parties supporting the government and day after the DMK petitioned the Election Commission of India (ECI) seeking to cancel ... Read More
Aichi-Nagoya, Sept. 22 -- India's women's badminton campaign ended in the Asian Games quarter-finals with a 3-1 defeat to hosts Japan here on Tuesday, but Treesa Jolly and Gayatri Gopichand provided a... Read More
Aichi-Nagoya, Sept. 22 -- India's defending champions produced another dominant display in men's kabaddi, while Sakshi Chaudhary made a statement on her Asian Games return by defeating an Olympic bron... Read More
New York, Sept. 22 -- General Secretary of the Communist Party of Vietnam Central Committee and President To Lam, together with the high-ranking Vietnamese delegation, attended a cultural event and me... Read More
Singapore, Sept. 22 -- The Health Sciences Authority received information related to the study titled 'Characteristics and durability of immune response to fractional dose compared to standard dose Ye... Read More
Singapore, Sept. 22 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, two-part, double-blind, randomized, placebo-controlled study to investigate the safety... Read More
Singapore, Sept. 22 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, double-blind, randomized, placebo controlled, 2-arm study to investigate the safety an... Read More
Singapore, Sept. 22 -- The Health Sciences Authority received information related to the study titled 'The use of Landiolol in mitral valve sUrgery: a raNdomized, controlled, double-blind triAl. (LUNA... Read More
Singapore, Sept. 22 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Open-label, Multicentre, Randomised Study Comparing Consolidation Treatment with AZD... Read More
Singapore, Sept. 22 -- The Health Sciences Authority received information related to the study titled 'A Phase 1/1b Study of IAM1363 in Participants with Advanced Cancers Harboring HER2 Alterations'. ... Read More